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This review discusses the biology and behavior of Propionibacterium acnes (P.acnes),
a dominant bacterium species of the skin biogeography thought to be associated with
transmission, recurrence and severity of disease. More specifically, we discuss the ability
of P. acnes to invade and persist in epithelial cells and circulating macrophages to
subsequently induce bouts of sarcoidosis, low-grade inflammation and metastatic cell
growth in the prostate gland. Finally, we discuss the possibility of P. acnes infiltrating the
brain parenchyma to indirectly contribute to pathogenic processes in neurodegenerative
disorders such as those observed in Parkinson’s disease (PD).
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GENERAL OVERVIEW
A large fraction of microorganisms not only reside within us but also live on us. Indeed, the
human skin harbors a heterogeneous mix of mostly non-pathogenic bacteria, fungi and viruses
that probably contribute to skin surface health (Figure 1). Propionibacterium acnes (P. acnes) is
a ubiquitous, slow growing, rod-shaped, non-spore forming, Gram-positive anaerobe (Figure 2)
found across body sites, including sebaceous follicles of the face and neck (Funke et al., 1997;
Grice and Segre, 2011; Findley and Grice, 2014). It is often considered part of our commensal
microbiota at barrier sites (Cogen et al., 2008) which is established via mechanisms of adaptive
immune tolerance during the early neonate period (Scharschmidt et al., 2015). Although the
topographical distribution of the anaerobe in sebaceous sites is significant, the spatial and personal
distribution of P. acnes is more individual-specific than site-specific (Oh et al., 2014). Moreover,
the biogeography and individuality of P. acnes is highly dynamic as changes in health or changes in
pH, temperature, moisture and/or sebum content may also affect the range of niches occupied by
the microorganism (Grice et al., 2009). Similar to the distribution of skin microbes, skin conditions
can also shape the function of P. acnes in terms of pathogen expansion in disease. For example, P.
acnes has been linked to skin insults such as acne vulgaris in the face and neck, and progressive
macular hypermelanosis on the back (Bojar and Holland, 2004; Kurokawa et al., 2009; Barnard
et al., 2016). In addition, certain disease-associated phylotypes of P. acnes have the ability to
persist on body implants and surgical devices causing a wide-range of post-operative infectious
conditions, such as endocarditis, endophthalmitis and intravascular nervous system infections
(Perry and Lambert, 2011; Portillo et al., 2013). The untoward features of P. acnes also extend to
the prostate gland where tissue invasion and intracellular deposition of the bacterium has been
Leheste et al. Propionibacterium acnes: Infectious Disease
FIGURE 1 | Schematic illustration of common microbes found at barrier sites in humans including P. acnes. While P. acnes is present on all external and
internal surfaces (i.e., oral and gastrointestinal epithelia, conjunctiva), it is most prevalent on the human skin. There it resides in hair follicles of the face and back where
it is associated with the common skin disease acne vulgaris. By most, P acnes is still considered a mostly benign and commensal microorganism, however, reports
about its malicious opportunistic side are increasing. Adapted and with kind permission from Bryan Christie Design (http://bryanchristiedesign.com/).
frequently noted in glandular epithelial cells and circulating
macrophages; a phenomenon thought to indirectly contribute to
benign prostate hyperplasia (BPH) and prostate cancer (Tanabe
et al., 2006; Alexeyev et al., 2007; Fassi-Fehri et al., 2011; Mak
et al., 2012; Bae et al., 2014; Davidsson et al., 2016). However, it
is not clear what the underlying mechanisms used by P. acnes are
to induce infection, inflammation and/or metastasis outside the
skin. What is known with some certainty is that bacteria-infected
keratinocytes, sebocytes and/or adipocytes secrete several pro-
inflammatory chemokines and cytokines as well as anti-microbial
factors (e.g., cathelicidin) hinting at specific disease mechanisms
(Graham et al., 2004; Nagy et al., 2006; Lee et al., 2010; Zhou et al.,
2015; Sanford et al., 2016; Yu et al., 2016).
SARCOIDOSIS
Sarcoidosis is a disease of unknown etiology that leads to
inflammation in organs as diverse as lungs, liver, skin and
lymphatics. A putative link of sarcoidosis with P. acnes was first
proposed when the bacteriumwas isolated from sarcoid lesions of
the skin and lymph nodes (Eishi et al., 2002; Yamada et al., 2002).
These findings have been significantly corroborated (de Brouwer
et al., 2015), and further expanded by various in vitro experiments
demonstrating the invasion capacity of P. acnes in HEK293T
(human embryonic kidney) and A549 (human alveolar epithelial
carcinoma) cell lines (Tanabe et al., 2006). Most recent work in
sarcoid broncho-alveolar lavage (BAL) fluid and cells showed
significant upregulation of a P. acnes-specific immune response
(Schupp et al., 2015). In addition, experiments in mice have
shown that viable P. acnes can induce pulmonary granulomas
similar to those observed in sarcoidosis patients (Werner et al.,
2017). A general overview detailing the link between sarcoidosis
and P. acnes is further given by Eishi (2013).
Studies attempting to characterize the signaling pathways
activated by P. acnes during infection showed that nuclear
factor-kappaB [NF-κB], a transcriptional factor that regulates
the expression of genes involved in immune and inflammatory
cascades is activated by P. acnes (Kim et al., 2002). More broadly,
toll-like receptor 2 (TLR2) was shown to be a critical receptor for
the NF-κB-dependent response to P. acnes, revealing the capacity
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FIGURE 2 | Scanning and transmission electron microscopic (SEM and TEM) images of P. acnes strain KPA (A, B = SEM; C, D = TEM). Recent advances
in isolation and culturing techniques are revealing that P. acnes infections have been grossly underestimated shedding a new light on this opportunistic bacterial
species. Microscopy by Volker Brinkmann, Max Planck Institute for Infection Biology, Berlin, Germany. Scale bar = 200/300nm.
of this bacterium to provoke the selective activation of innate
immunity genes (Inohara and Nuñez, 2001; Chamaillard et al.,
2003; Moreira and Zamboni, 2012). Furthermore, the role of host
genetics was examined in sarcoidosis cases that were associated
with P. acnes infection. Single nucleotide polymorphisms (SNPs)
in the nucleotide-binding oligomerization domain (NOD) of
proteins NOD1 and NOD2 were correlated with P. acnes
infection among 73 sarcoidosis patients with 52 interstitial
pneumonia and 215 healthy controls (Tanabe et al., 2006).
NOD1 and NOD2 are intracellular pattern recognition receptors
that can sense bacterial molecules such as peptidoglycan
moieties. Along the same lines, in vitro experiments have
shown that internalization of P. acnes into HEK293T cells
can result in activation of NOD1 and NOD2, suggesting a
disease mechanism based on chronic inflammation or local
immunosuppression (Tanabe et al., 2006). These findings also
suggest that invasive P. acnes can act as bacterial ligands to
cause aberrant NOD receptor activation in certain individuals
with long-lasting susceptibility to sarcoidosis. However, future
experiments have to clarify the exact mechanistic chronology of
whether or how P. acnes-mediated aberrant NF-κB activation
may induce granuloma formation in a NOD1/NOD2-dependent
manner.
Although invasive P. acnes could be a possible etiology of
sarcoidosis and perhaps other diseases, elucidating causation and
correlation between P. acnes infection and pathology is murky
as bacterial strain heterogeneity, host genetics as well as host’s
environments must be considered whenever a study links a
microbiome to a disease state.
BENIGN PROSTATE HYPERPLASIA (BPH)
AND PROSTATE CANCER
Chronic or recurrent inflammatory processes have long been
implicated in the progression of BPH and prostate cancer
(De Marzo et al., 1999; Nelson et al., 2004; Sfanos et al.,
2014). Inflammation is attributed to the presence of specific
biomarkers such as elevated interleukin (IL)-6, tumor necrosis
factor alpha (TNFα) and the acute phase protein, C reactive
protein (Mechergui et al., 2009; Menschikowski et al., 2013; Yu
et al., 2015). Recent work on urological fluids (i.e., urine, seminal
fluid, prostatic secretions) as well as prostate biopsies suggests
a significant conditional shift toward certain microbial species
which may be used as a diagnostic index (Yu et al., 2015; Ni et al.,
2016).
A good amount of work is suggesting that the specific
association of P. acnes with the prostate and the invasion of
prostate epithelial cells in particular (Figure 3) may contribute
to the pathology of BPH or prostate cancer with an inflammatory
component (Sfanos et al., 2013; Davidsson et al., 2016). However,
it is currently unclear whether P. acnes represents a true
infectious agent of the prostate, a commensal or accidental
prostate microbion. It is plausible that prostate-located P. acnes
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FIGURE 3 | SEM of P. acnes strain P6 (arrow) in vitro on cultured
prostate epithelial cells RWPE1. The prostate epithelial cell-invasive
behavior of P. acnes is well documented in both, in vivo and cell-based studies
where a vimentin-mediated invasion process looks likely (Mak et al., 2012).
Microscopy by Volker Brinkmann, Max Planck Institute for Infection Biology,
Berlin, Germany. Scale bar = 2 µm.
are derived from the skin that are accidentally introduced, for
instance during a prostate biopsy—a viewpoint that should raise
concerns with certain diagnostic workup scenarios.
Whatever the route of entry or pathogenic potential,
a significant number of prostate tissues obtained through
transurethral resection for BPH, or radical prostatectomy for
cancer, were previously tested positive for P. acnes aggregates
apparently residing within roving macrophages (Alexeyev
et al., 2007; Bae et al., 2014). Additional reports based on
human samples have provided further evidence for a link
between BPH or prostate cancer and P. acnes using various
technical approaches, including cultivation, confocal microscopy
for visualization of the bacterium and in situ hybridization,
immunohistochemistry (Figure 4) and PCR-based profiling of
bacterial 16S rRNA (Hochreiter et al., 2000; Cohen et al.,
2005; Sfanos et al., 2008; Fassi-Fehri et al., 2011; Bae et al.,
2014; Davidsson et al., 2016). Further evidence comes from
animal studies indicating that inoculation of P. acnes into the
murine or rat prostate and bladder leads to an overt, long-term
inflammatory response and a wide-range of cellular disturbances
within the prostate gland (Olsson et al., 2012; Shinohara et al.,
2013).
Attempts to phylogenetically analyze disease-associated
P. acnes strains from cancerous prostate glands have revealed
that most prostate isolates belong to phylogenetic clades that are
rare on human skin, indicating that a skin-derived contamination
during sampling is unlikely (Mak et al., 2013; Davidsson et al.,
2016). Along the same lines, similar inflammatory pathways as
those described for sarcoidosis, including NF-κB, IL-6, STAT3
and COX2, appear to be activated by P. acnes both under in
situ and in vitro conditions (Drott et al., 2010; Fassi-Fehri
et al., 2011; Mak et al., 2013; Tsai et al., 2013; Bae et al., 2014).
Although the precise etiology for these inflammatory changes
FIGURE 4 | Immunohistochemistry of human prostate tissue samples
stained with P. acnes antibody (red). Adapted with permission from
Fassi-Fehri et al., 2011 (Supplementary Figure 2B). Presence of P. acnes in
human prostate tissue samples with benign prostatic hyperplasia (A,B); or
adenocarcinoma (C,D). Extensive bacterial load was detected in both cases.
is not yet clear, several membrane-bound pattern recognition
receptor pathways are broadly distributed in mammalian urinary
and genital systems that avidly recognize bacterial and viral
components (Jorgensen and Seed, 2012; Gambara et al., 2013).
These host cell receptors, for example TLRs, promote cytokine
production which is a core feature of innate immunity against
microbial pathogens. Collectively, these findings suggest that
through their capacity to trigger various aspects of immunity,
invading P. acnes can act as primary driver and/or amplifier of
disease severity.
SPONDYLODISCITIS AND BACK PAIN
One of several post-operative complications involving P. acnes
is inflammation of the intervertebral disk and the surrounding
intervertebral space (diskitis) following discectomy (Harris et al.,
2005). Concomitant degenerative infection of adjacent vertebrae
(spondylodiscitis) can be a common feature and the root
cause for serious neurological damage and pain if treatment
is delayed (Uçkay et al., 2010). Aside from unintentional
surgical introduction right into the vertebral column, pathogens
can also arrive through the arterial and venous spinal blood
supply (hematogenous spreading). While Staphylococcus aureus,
Escherichia coli, and Proteus species are most commonly isolated,
P. acnes is the most abundant anaerobic pathogen in this
context and likely underreported due to culturing challenges.
There has been some clinical evidence that patients with
herniated nuclear (nucleus pulposus) disk material infected with
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anaerobic pathogens in general, and P. acnes in particular, are
more likely develop inflammation and edema of the adjacent
vertebrae (Modic changes type I) and back pain (Albert et al.,
2013; Urquhart et al., 2015). Clinical and animal-based follow-
ups are now corroborating the initial findings showing that
local P. acnes proliferation causes upregulation of inflammatory
markers and disk degeneration consistent with Modic changes
(Aghazadeh et al., 2016; Dudli et al., 2016). There is now
even first clinical evidence to suggest that bacterial infection
of the intervertebral disk with P. acnes and/or Staphylococcus
epidermidis may actually precede all other issues as the root
cause of disk herniation and associated pathological changes
(Rajasekaran et al., 2017).
PARKINSON’S DISEASE (PD)
The degenerating brain is characterized by neural system
damage that may be attributed to atypical aggregation and
deposition of mutant or misfolded proteins (e.g., Lewy bodies
and Lewy neurites) as clearly documented in idiopathic PD
(Taylor et al., 2002). What is generally not appreciated is that
the brain is also susceptible to invading pathogens ranging
from viruses and bacteria to fungi. These pathogens, or more
specifically their endogenous components and/or metabolites,
can produce central neurological deficits ranging from subtle
signs of dementia and dystonia, which result from chronic,
recurrent infection (De Chiara et al., 2012; Bibi et al., 2014),
to more severe motor neuron disease as for example observed
with the human endogenous retrovirus K (Li et al., 2015). Thus,
it is clear that humans have a tremendously heavy systemic
burden of microbes (Potgieter et al., 2015; Spadoni et al.,
2015) which may incidentally contribute to the pathology of
progressive neurodegenerative diseases with atypical protein
component. Certainly, this working hypothesis is gaining
considerable support as cognitive, emotional or pathological
behavior appear to be indirectly affected by the spatial and
personal distribution of microbes acting through the gut-
brain axis (Figure 5) (Collins et al., 2012; Dinan et al., 2013;
Mayer et al., 2014; Burokas et al., 2015). Indeed, a recent
case-control study demonstrated that microbial variation in
the gastrointestinal tract, both between and within individuals;
correspond most significantly to phenotypical variations in PD
(Scheperjans et al., 2015; Vizcarra et al., 2015). Although the
underlying mechanisms linking microbiota composition with
differences in PD are not clear, the above finding might at
least explain the high prevalence of gastrointestinal abnormalities
seen in PD patients (Dobbs et al., 2016). Further linking
the microbiota to PD severity, sigmoid mucosal biopsies and
fecal material collected from PD patients showed the presence
of opportunistic and pro-inflammatory bacterial species that
often cause chronic constipation, irritable bowel syndrome
and ulcerative colitis (Keshavarzian et al., 2015). Collectively,
these initial results suggest that relationships between different
microbial communities in the gut are a common comorbidity in
PD, and that unique individual signatures of the gut ecosystem
can reinforce classic motor impairments of PD.
Against this background, the question to be asked is whether
there is any evidence that P. acnes plays any role in the
pathophysiology of PD. For this possibility to occur, two
conditions must be met: (1) P. acnes infection must precede the
occurrence of classic symptoms of the disease such as shaking,
motor initiation and slowness of movement; and (2) P. acnes
inoculation must sufficiently induce symptoms of PD and/or
lead to the loss of dopamine projection neurons in the midbrain
nucleus known as substantia nigra pars compacta. So far, our
laboratory has detected clusters of P. acnes localized to neurons
of the midbrain and nearby cortical structures of autopsied PD
brains (Figure 6). This unexpected finding adds further credence
of P. acnes indirectly contributing to local bouts of inflammation
similar to those seen in sarcoidosis and BPH. An open question
is the extent to which P. acnes can indirectly enhance certain
pathological features of PD. As PD is a highly heterogeneous
disorder, it is unlikely that one disease mechanism applies to all
PD phenotypes. Nevertheless, it is intriguing to speculate that
resident skin microbes could initiate or amplify PD progression
through inflammatory and/or genetic predisposition factors.
If P. acnes can gain access to dopamine cells in the midbrain,
what is the most likely route of inoculation and infection?
Although the skin is physically compartmentalized from the
brain, cross-inoculation remains a risk factor. For example, the
nares could potentially harbor pathogenic P. acnes strains which
would then translocate to the brain parenchyma to hyper-activate
local macrophages called microglia; a phenomenon that is a
FIGURE 5 | Schematic illustration of the gut-brain axis (colored) with
the microbe-filled digestive system on one end and the brain with its
homeostasis centers (hypothalamus and pituitary) on the other. Both
are connected through the cardiovascular and autonomic nervous system
including the vagus nerve (cranial nerve X) which could facilitate microbial
transition into the central nervous system (CNS). Kindly with permission from
Bryan Christie Design (http://bryanchristiedesign.com/).
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FIGURE 6 | Immunohistochemistry of human PD midbrain tissue samples stained for P. acnes (green; A+B), neuronal microtubules (MAP2; red; A) and
nuclei (DAPI; blue; A+B). Age-linked lipofuscin auto-fluorescence was extinguished with Sudan Black B. Presence of P. acnes (arrow) in the periplasmic space of a
human neuron (A) between nucleus (n) and cytoskeleton; or neutrophil (B) with its characteristic multi-lobed nucleus inside a midbrain capillary (Cap). These findings
are typical for PD and absent in most control sections. Retrograde movements along cranial nerves, trauma-induced micro-bleeds as well as the newly discovered
glymphatic system represent potential microbial pathways into the CNS.
consistent feature of PD pathology (reviewed by Chao et al.,
2014). Research into nosocomial infections demonstrate bacterial
species as diverse as Pneumococcus sp. (Zwijnenburg et al.,
2001) and Salmonella sp. (Bollen et al., 2008) roving readily
along the olfactory nerve (cranial nerve 1; CN 1) and eventually
into the olfactory bulb. Another potential route of entrance
for harmful microbes or dangerous misfolded proteins is the
vagus nerve (cranial nerve 10; CN 10). Indeed under some
circumstances, misfolded aggregates in the form of Lewy bodies
and Lewy neurites appear to migrate from the vagus nerve to
the brain, providing further evidence for pathogenic bacteria
in association with toxic proteins to potentially contribute to
selective neuronal vulnerability (Holmqvist et al., 2014). Of
interest, brain nuclei of CN 1 and CN 10 are among the first
sites to preferentially show deposition of Lewy bodies and Lewy
neurites during the course of PD progression (Braak et al.,
2004). This particular observation not only highlights a likely
route of entrance for bacteria into the brain, but also provides
a potential mechanism for the observation that truncal vagotomy
significantly decreases the PD risk (Svensson et al., 2015). The
link between head trauma and PD (Harris et al., 2013; Jafari
et al., 2013; Pearce et al., 2015), together with the notion of a
diverse blood microbiome (Potgieter et al., 2015), implies a vast
potential for pathogenic opportunism as traumatic breaches in
the blood brain barrier occur.With the recent discovery of a brain
lymphatic (glymphatic) system (Iliff et al., 2012; Hitscherich
et al., 2016) another potential route of brain infection must be
considered.
Taken together, there is preclinical and some clinical
evidence to indirectly implicate P. acnes as an independent
variable affecting PD incidence or severity. This evidence is
complemented by reports associating a severe skin disorder, acne
inversa, with Alzheimer’s disease (Wang et al., 2010). From a
therapeutic perspective, the possibility of P. acnes driving or
amplifying core features of PD represents an important resource
for antibiotic approaches to neurodegenerative diseases. And
from a research perspective, it would be worthy to examine
patients with skin disorders more closely for evidence of
neuropathology with earlier onset and a more severe disease
phenotype.
FUTURE OUTLOOK
The review presented in this article outlines an unexpected
dark side of P. acnes with respect to pathology. Intracellular
persistence of P. acnes is implicated in diseases of the lungs and
prostate gland and possibly the brain. This is a clear testimony
for the pathogenicity of skin-derived bacteria in certain disease
phenotypes. Further investigation will need to focus on several
looming questions in P. acnes biology: (1) what are the crucial
P. acnes interactions in disease susceptibility? (2) What are the
mechanisms used by P. acnes to influence disease progression?
(3) If certain populations of P. acnes can enhance susceptibility
to disease severity, are there other configurations of P. acnes
that are protective? (4) Proof of concept that P. acnes infection
directly associates with disease pathology, or more specifically,
does the study of concept show causation or just correlation? And
finally (5) Can P. acnes-driven disease pathology be treated with
conventional antibiotic therapy and diagnostic applications?
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